Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Feb 06, 19:18

BioNTech Hire Signals People Focus As Oncology Plans And Valuation Attract Attention

BioNTech SE
Webhose 2026 Feb 05, 06:58

BioNTech (NASDAQ:BNTX) Cut to Market Perform at Leerink Partners - Zolmax

BioNTech SE
Webhose 2026 Feb 05, 00:00

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy

BioNTech SE
Webhose 2026 Feb 03, 19:27

BioNTech Adds Chief People Officer To Support Oncology Growth Plans

BioNTech SE
Webhose 2026 Feb 02, 13:15

Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus

BioNTech SE
Webhose 2026 Feb 02, 12:43

BioNTech (NASDAQ:BNTX) Rating Lowered to Market Perform at Leerink Partners

BioNTech SE
Webhose 2026 Feb 02, 00:00

Africa's deep tech boom rests on a fragile research ecosystem

BioNTech SE
Webhose 2026 Jan 31, 13:25

Lingohr Asset Management GmbH Acquires 40,821 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jan 31, 12:32

Privium Fund Management B.V. Acquires 8,013 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jan 31, 05:25

BioNTech SE Sponsored ADR $BNTX Shares Purchased by Lingohr Asset Management GmbH - Daily Political

BioNTech SE
Webhose 2026 Jan 31, 01:56

BioNTech (NASDAQ:BNTX) vs. uniQure (NASDAQ:QURE) Critical Analysis - Daily Political

BioNTech SE
Webhose 2026 Jan 30, 07:07

Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline

BioNTech SE
Webhose 2026 Jan 30, 05:33

BioNTech Advances Oncology Focus With BNT324 Trial And Leadership Shift

BioNTech SE
Webhose 2026 Jan 29, 05:00

Appointments and advancements for Jan. 29, 2026 | BioWorld

BioNTech SE
Webhose 2026 Jan 28, 14:13

BioNTech SE (BNTX): A Bull Case Theory

BioNTech SE
Webhose 2026 Jan 28, 10:26

BioNTech SE's (NASDAQ:BNTX) Price Is Right But Growth Is Lacking After Shares Rocket 26% - Simply Wall St News

BioNTech SE
Webhose 2026 Jan 27, 02:25

Is BioNTech (BNTX) Pricing Reflect Its mRNA Pipeline Potential After Recent Share Price Gains

BioNTech SE
Webhose 2026 Jan 26, 14:00

BioNTech Shares Surge in 2026 as Analysts See Further Upside

BioNTech SE
Webhose 2026 Jan 26, 13:00

Lbp Am Sa Acquires 47,859 Shares of BioNTech SE Sponsored ADR $BNTX - Zolmax

BioNTech SE
Webhose 2026 Jan 26, 12:26

BioNTech SE Sponsored ADR $BNTX Holdings Boosted by Lbp Am Sa

BioNTech SE
Webhose 2026 Jan 26, 07:39

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2026 Jan 25, 12:26

Sector Gamma AS Has $2.74 Million Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jan 24, 11:27

BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed?

BioNTech SE
Webhose 2026 Jan 24, 09:09

Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jan 23, 14:26

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank

BioNTech SE
Webhose 2026 Jan 22, 10:35

US Stock Market Today: S&P 500 Futures Rise On Cooling Inflation And Housing Jitters - Simply Wall St News

BioNTech SE
Webhose 2026 Jan 21, 23:44

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss

BioNTech SE
Webhose 2026 Jan 21, 21:42

BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why

BioNTech SE
Webhose 2026 Jan 19, 00:56

The Stock Market Is Closed on MLK Day, but Here's What Goldman Sachs Says to Buy When Trading Resumes | Markets Insider

BioNTech SE
Webhose 2026 Jan 16, 18:28

BioNTech (BNTX) Is Up 7.3% After Unveiling Ambitious Late-Stage Oncology Pipeline Expansion

BioNTech SE
Webhose 2026 Jan 15, 10:58

SG Americas Securities LLC Sells 69,726 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2026 Jan 14, 11:33

A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update

BioNTech SE
Webhose 2026 Jan 14, 09:04

BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan

BioNTech SE
Webhose 2026 Jan 09, 13:51

Big Pharma turf war erupts: Bayer sues vaccine makers over alleged stolen mRNA technology - NaturalNews.com

BioNTech SE
Webhose 2026 Jan 09, 02:30

Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge

BioNTech SE
Webhose 2026 Jan 09, 00:00

Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms

BioNTech SE

BioNTech News

Ghko B 2026 Feb 05, 16:00

Will DJT skyrocket in 2026: Is DJT stock a good long-term investment?

Ghko B 2026 Feb 05, 16:00

XRP price analysis: XRP/USD slides, what’s going on with Ripple?

Frances Wang 2026 Feb 04, 16:00

Gold price forecast: XAU/USD is above $4,900, is gold market expected to rise?

Ghko B 2026 Feb 04, 16:00

Why stock market is down: Dow DJIA slides, S&P 500 sinks, Nasdaq dips

Ghko B 2026 Feb 04, 16:00

AI stocks and investment opportunities: What are the best ai stocks to invest in?

Ghko B 2026 Feb 04, 16:00

Crypto Trend Insight 2026: XRP Price Movements and Market Analysis

Frances Wang 2026 Feb 04, 16:00

Bitcoin price prediction: Will bitcoin outperform stocks and gold in 2026?

Ghko B 2026 Feb 04, 16:00

AI stocks to watch: Why Broadcom (AVGO) stock, NVDA stock and AMD are down?

Ghko B 2026 Feb 03, 16:00

Best Retail Stocks to Buy: Amazon (AMZN) stock, WMT stock, Home Depot

Ghko B 2026 Feb 01, 16:00

ETF trading for beginners: What’s the best S&P 500 ETF to invest in 2026?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

1.4402

Spread (%)

1.3590 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

26754236416

Shares Outstanding

250930737

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.81

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Georgy Istigechev 2026 Feb 02, 16:00

CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

Ghko B 2026 Jan 29, 16:00

CFD trading basics: Long position VS. short position, which is better?

Ghko B 2026 Jan 27, 16:00

What is a stochastic indicator: How to read the stochastic indicator?

Trustpilot